Alcon 

$67.65
262
+$0.80+1.19% 今天

統計

當日最高
67.03
當日最低
66.1
52週高點
92.22
52週低點
62.02
成交量
1,242,400
平均成交量
-
市值
0
本益比
40.03
股息殖利率
0.54%
股息
0.36

即將到來

股息

0.54%股息殖利率
May 26
$0.36
May 25
$0.33
May 24
$0.26
May 23
$0.24
May 22
$0.20
10年成長
不適用
5年成長
26.73%
3年成長
15.05%
1年成長
7.99%

財報

10Aug預期
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
下一步
0.69
0.74
0.79
0.84
預期EPS
0.7505373561
實際EPS
不適用

財務

9.42%利潤率
有盈利
2020
2021
2022
2023
2024
2025
20.8B營收
1.96B淨利

分析師評級

85.43平均目標價
最高預估為 95.00。
來自過去6個月內的 7 則評分。這不是投資建議。
買入
71%
持有
29%
賣出
0%

其他人也在關注

此清單是根據在 Stock Events 上追蹤 ALC 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Alcon Inc. is a global leader in eye care, engaging in the comprehensive lifecycle of ophthalmic solutions, from initial research and development to manufacturing, distribution, and worldwide sales. Its diverse portfolio serves both eye care professionals and the patients they treat across the globe. The company's operations are divided into two main segments: 1. Surgical Segment: This division provides a vast array of products crucial for ophthalmic surgical procedures. Offerings encompass advanced equipment, sophisticated diagnostic tools, and implantable devices such as intraocular lenses (IOLs). It also supplies essential consumables, including viscoelastics, specialized surgical solutions, incisional instruments, and custom surgical procedure packs. Key product areas within this segment feature: Cataract Management: Technologies like the Centurion Vision System, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and the ORA system for intra-operative measurements, along with custom pak surgical procedure kits. Vitreoretinal Interventions: Including Constellation Vision Systems, procedure packs, lasers, hand-held microsurgical instruments (such as grieshaber and MIVS), a range of scissors, forceps, micro-instruments, medical-grade vitreous tamponades, and Hypervit vitrectomy probes. Refractive Correction: WaveLight lasers and Contoura Vision, specifically utilized for LASIK treatments. Glaucoma Solutions: The EX-PRESS glaucoma filtration device. Advanced Implantables: Such as AcrySof IQ IOLs, which include both monofocal IOLs and cutting-edge technology IOLs marketed under the PanOptix and ReSTOR brands, designed to correct presbyopia and astigmatism during cataract surgery. 2. Vision Care Segment: This segment delivers products aimed at daily vision needs and overall ocular health. Its offerings include daily disposable, reusable, and color-enhancing contact lenses. Furthermore, it provides a variety of eye health products addressing issues like dry eye, glaucoma, contact lens maintenance, and ocular allergies, alongside eye vitamins and redness relievers. These are available under prominent brands such as TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux. Established in 1945, Alcon Inc. changed its name from Alcon Universal S.A. to its current designation in December 2001. The company's corporate headquarters are located in Geneva, Switzerland.
Show more...
執行長
Mr. David J. Endicott
員工
25599
國家
美國
ISIN
CH0432492467

上市

0 Comments

分享你的想法

FAQ

Alcon 今天的股價是多少?
ALC 目前價格為 $67.65 USD,過去 24 小時上漲了 +1.19%。在圖表上更密切關注 Alcon 股價表現。
Alcon 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Alcon 的股票以代號 ALC 進行交易。
Alcon 的股價在上漲嗎?
ALC 股票較上週上漲 +2.32%,本月上漲 +6.29%,但過去一年 Alcon 下跌 -21.53%。
Alcon 下一次財報日期是什麼時候?
Alcon 將於 August 10, 2026 公布下一次財報。
Alcon 上一季度的財報如何?
ALC 上一季度的財報為每股 0.83 USD,預估為 0.8 USD,帶來 +4.1% 的驚喜。下一季度的預估財報為每股 不適用 USD。
Alcon 去年的營收是多少?
Alcon 去年的營收為 20.8BUSD。
Alcon 去年的淨利是多少?
ALC 去年的淨收益為 1.96BUSD。
Alcon 會發放股息嗎?
是的,ALC 的股息每 年度 發放一次。每股最新股息為 0.36 USD。截至今日,股息殖利率(FWD)% 為 0.54%。
Alcon 有多少名員工?
截至 June 15, 2026,公司共有 25,599 名員工。
Alcon 位於哪個產業?
Alcon從事於Health & Wellness產業。
Alcon 何時完成拆股?
Alcon 上次拆股發生於 June 16, 2011,比例為 2:1。
Alcon 的總部在哪裡?
Alcon 的總部位於 美國 的 Geneva。